Stocks › INO
INOVIO PHARMACEUTICALS, INC.
INO·Nasdaq·
United States·USD
United States·USD$1.16
+0.03 (+2.21%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
INO
INOVIO PHARMACEUTICALS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INOS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of INO by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
INOINOVIO PHARMACEUTICALS, INC. · Stock |
Sale $1,001 - $15,000 |
Nov 6, 2020 | Sep 8, 2020 | Filing ↗ |
Whale Activity
Position changes in INO reported for 2026-06-30 by 7 tracked institutional filers
- Increased3
- New0
- Held0
- Decreased4
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | $4.0M | increased |
| D. E. Shaw & Co., Inc. | 1.4M | $1.5M | decreased |
| TWO SIGMA INVESTMENTS, LP | 1.2M | $1.4M | increased |
| MILLENNIUM MANAGEMENT LLC | 796.1K | $876K | decreased |
| BlackRock, Inc. | 779.1K | $857K | increased |
| RENAISSANCE TECHNOLOGIES LLC | 361.3K | $397K | decreased |
| CITADEL ADVISORS LLC | 241.8K | $266K | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by INO insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
626 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sumner Michael JohnChief Medical Officer | Tax withholding | −2,693 | $1.23 | $3K | May 20, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Option exercise | +9,450 | — | — | May 20, 2026 | Form 4 ↗ |
| Shea Jacqueline ElizabethChief Executive Officer · Director | Tax withholding | −12.3K | $1.23 | $15K | May 20, 2026 | Form 4 ↗ |
| Shea Jacqueline ElizabethChief Executive Officer · Director | Option exercise | +28.3K | — | — | May 20, 2026 | Form 4 ↗ |
| Humeau LaurentChief Scientific Officer | Tax withholding | −2,163 | $1.23 | $3K | May 20, 2026 | Form 4 ↗ |
| Humeau LaurentChief Scientific Officer | Option exercise | +6,027 | — | — | May 20, 2026 | Form 4 ↗ |
| KIES PETERCFO | Tax withholding | −4,688 | $1.23 | $6K | May 20, 2026 | Form 4 ↗ |
| KIES PETERCFO | Option exercise | +8,700 | — | — | May 20, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Tax withholding | −680 | $1.30 | $884 | May 15, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Option exercise | +2,385 | — | — | May 15, 2026 | Form 4 ↗ |
| Shea Jacqueline ElizabethChief Executive Officer · Director | Tax withholding | −7,717 | $1.30 | $10K | May 15, 2026 | Form 4 ↗ |
| Shea Jacqueline ElizabethChief Executive Officer · Director | Option exercise | +17.7K | — | — | May 15, 2026 | Form 4 ↗ |
| Humeau LaurentChief Scientific Officer | Tax withholding | −1,712 | $1.30 | $2K | May 15, 2026 | Form 4 ↗ |
| Humeau LaurentChief Scientific Officer | Option exercise | +4,771 | — | — | May 15, 2026 | Form 4 ↗ |
| KIES PETERCFO | Tax withholding | −2,571 | $1.30 | $3K | May 15, 2026 | Form 4 ↗ |
| KIES PETERCFO | Option exercise | +4,771 | — | — | May 15, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Tax withholding | −1,223 | $1.74 | $2K | Mar 31, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Option exercise | +4,292 | — | — | Mar 31, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Tax withholding | −3,903 | $1.79 | $7K | Feb 26, 2026 | Form 4 ↗ |
| Sumner Michael JohnChief Medical Officer | Option exercise | +11.6K | — | — | Feb 26, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding INO · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 7.0M | $4.7M | 0.05% | Jul 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $2.9M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 3.5M | $2.4M | 0.05% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 963.3K | $1.1M | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 348.0K | $456K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF iShares Trust | 280.1K | $308K | 0.02% | Jun 30, 2026 |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 173.0K | $190K | 0.19% | Jun 30, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 104.0K | $136K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 96.1K | $126K | 0.00% | May 31, 2026 |
| Small Cap Core Fund NORTHERN FUNDS | 47.3K | $82K | 0.02% | Mar 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list INO's shares (CUSIP 45773H409), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Phillip GrossSCHEDULE 13G/A · passive (13G) · 3.4M shares4.0%
Aug 12, 2026 · ↗ - Robert AtchinsonSCHEDULE 13G/A · passive (13G) · 3.4M shares4.0%
Aug 12, 2026 · ↗ - Adage Capital Management, L.P.SCHEDULE 13G/A · passive (13G) · 3.4M shares4.0%
Aug 12, 2026 · ↗ - RA Capital Healthcare Fund, L.P.SCHEDULE 13G · passive (13G) · 10.7M shares9.9%
Aug 7, 2026 · ↗ - Rajeev ShahSCHEDULE 13G · passive (13G) · 10.7M shares9.9%
Aug 7, 2026 · ↗ - Peter KolchinskySCHEDULE 13G · passive (13G) · 10.7M shares9.9%
Aug 7, 2026 · ↗ - RA Capital Management, L.P.SCHEDULE 13G · passive (13G) · 10.7M shares9.9%
Aug 7, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 8.5M shares10.3%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 8.5M shares10.3%
Aug 6, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 4.2M shares5.0%
Jul 31, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming inovio pharmaceuticals as client
- INOVIO PHARMACEUTICALS, INC.INOVIO PHARMACEUTICALS, INC. · 2024 Q2$10K
Filing ↗ - INOVIO PHARMACEUTICALS, INC.INOVIO PHARMACEUTICALS, INC. · 2024 Q1$20K
Filing ↗ - INOVIO PHARMACEUTICALS, INC.INOVIO PHARMACEUTICALS, INC. · 2023 Q4—
Filing ↗ - INOVIO PHARMACEUTICALS, INC.INOVIO PHARMACEUTICALS, INC. · 2023 Q3 · HCR$50K
Filing ↗ - INOVIO PHARMACEUTICALS, INC.INOVIO PHARMACEUTICALS, INC. · 2023 Q2 · HCR$60K
Filing ↗
Government Contracts
Federal awards to INOVIO PHARMACEUTICALS, INC. · USAspending
No federal contract awards found for INOVIO PHARMACEUTICALS, INC..
U.S. Patents
Recent USPTO applications naming INOVIO PHARMACEUTICALS, INC.
No USPTO patent applications found for INOVIO PHARMACEUTICALS, INC..
Annual Financials
From INO's 10-K filings · XBRL
No annual XBRL figures on record for INO. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-12Reverse splitJan 25, 2024
- 1-for-4Reverse splitJun 6, 2014
- 1-for-4Reverse splitSep 13, 2004
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.03, 9.01Bylaw amendmentOct 6, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 12, 2026
EDGAR ↗ - 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsJul 31, 2026
EDGAR ↗ - 8-K · Items 2.02Results of operationsJul 29, 2026
EDGAR ↗ - 8-K · Items 5.03, 5.07, 9.01Bylaw amendment · Shareholder voteMay 20, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 13, 2026
EDGAR ↗
About INOVIO PHARMACEUTICALS, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersPLYMOUTH MEETING, PA
IncorporatedDE
SEC CIK0001055726 ↗
Former namesINOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD